Drawing for VIVA|SCREEN

USPTO serial 79109519

VIVA|SCREEN

Reviewed by CopyMark Law Group

Reg. 4277773Status 404
Filing date
Status date
Registration date
Jan 22, 2013
Examiner
WIENER, MICHAEL
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with VIVA|SCREEN?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

BREWSTER TAYLOR

BREWSTER TAYLOR STITES & HARBISON PLLC1800 DIAGONAL ROADSUITE 325ALEXANDRIA, VA 22314

Goods and services

ClassDescriptionStatusFirst use
001Molecules obtained from biotechnologies, namely, proteins in raw material form for industrial use, scientific or medical research; biotechnological products for research and diagnosis, namely, chemicals, antibodies, antigens; micro-organisms, namely, cultures of microorganisms other than for medical and veterinary use; cells for scientific and laboratory uses; pre made and biological cell lines for scientific and laboratory uses; viruses for scientific and laboratory uses; nucleotides for use as biochemical reagents; plasmids for use as biochemical reagents; DNA or RNA sequences for use as biochemical reagents; antibodies for scientific and industrial research; cells for cloning for the production of antibodies; vectors for research and diagnosis; all of the previous products being not for medical or veterinary purposes; biological preparations for use in cell cultures other than for medical or veterinary purposes; bacteriological preparations for use in cell cultures other than for medical and veterinary useSECTION 71 - CANCELLED—
005Prophylactic and therapeutic medicines and pharmaceutical products for the prevention, diagnosis and cure of diseases that induce an immune response; Prophylactic and therapeutic veterinary products for the prevention, diagnosis and cure of diseases that induce an immune response; biological, biotechnological preparations and products obtained via genetic technology for medical or pharmaceutical purposes in the nature of preventing, diagnosing and curing diseases that induce an immune response; biological, biotechnological preparations and products obtained via genetic technology for veterinary purposes in the nature of preventing, diagnosing and curing diseases that induce an immune response; micro-organisms; cells; cell lines; viruses; nucleotides; plasmids; DNA or RNA sequences; antibodies; cell clones producing antibodies; vectors for therapy and diagnostic for medical purposes; molecules and antibodies, all for medical and pharmaceutical purposes in the nature of cell cultures, biochemical reagents, reagents for sample preparation, reagents for targeting and recovering targeted cells; biotechnological products for medical and pharmaceutical purposes in the nature of cell cultures, biochemical reagents, reagents for sample preparation, reagents for targeting and recovering targeted cells; products for diagnosis for medical and pharmaceutical purposes, namely, proteins, antibodies, and products comprising these molecules for the diagnosis of diseases that induce an immune response; prophylactic or therapeutic vaccinesSECTION 71 - CANCELLED—
009Scientific apparatus and instruments, namely, typical equipment used in laboratories to take blood samples, to harvest biological cells, to select targeted cells, and microarrays chips for the identification and/or isolation of antibodies or the separation and recovery of cell clones producing antibodies in biological samplesSECTION 71 - CANCELLED—
042Scientific services, namely, research and development of new products or process for production and/or purification of biological products for third parties; biological research; bacteriological, virology, immunology, biotechnology, genetic, medicine and pharmacology research; scientific research services for medical purposes; scientific research services for pharmaceutical purposes; scientific research services for veterinary purposes; development of new technologies for others in the field of biotechnology, biological and medical research; development of scientific and industrial research means inter alia to identify and isolate antibodies or cell clones producing antibodiesSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 5, 2022DENCNOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED—
Jun 5, 2022DETHDEATH OF INTERNATIONAL REGISTRATION—
Jul 10, 2020INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Jun 8, 2020INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Jun 8, 2020INPCINVALIDATION PROCESSED—
Apr 23, 2020INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Sep 26, 2019NREPNEW REPRESENTATIVE AT IB RECEIVED—
Aug 23, 2019C71TCANCELLED SECTION 71—
Jan 22, 2018REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
May 15, 2017TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Feb 28, 2014ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
May 14, 2013FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Apr 25, 2013FICSFINAL DISPOSITION NOTICE SENT TO IB—
Apr 25, 2013FIMPFINAL DISPOSITION PROCESSED—
Apr 22, 2013FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Mar 2, 2013NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jan 22, 2013R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Dec 15, 2012GPNXNOTIFICATION PROCESSED BY IB—
Nov 6, 2012PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 17, 2012OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Oct 17, 2012OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Oct 17, 2012NPUBNOTICE OF PUBLICATION—
Sep 28, 2012PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Sep 21, 2012CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 21, 2012TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 21, 2012CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 20, 2012ALIEASSIGNED TO LIE—
Sep 19, 2012TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 14, 2012NREPNEW REPRESENTATIVE AT IB RECEIVED—
Sep 5, 2012TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jul 27, 2012NREPNEW REPRESENTATIVE AT IB RECEIVED—
Apr 14, 2012RFNTREFUSAL PROCESSED BY IB—
Mar 22, 2012RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Mar 22, 2012RFRRREFUSAL PROCESSED BY MPU—
Mar 22, 2012RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Mar 21, 2012CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 20, 2012MAFRAPPLICATION FILING RECEIPT MAILED—
Mar 14, 2012DOCKASSIGNED TO EXAMINER—
Mar 14, 2012NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 13, 2012REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance